Open label, multicenter, 28-week extension study of the safety and tolerability of memantine in patients with mild to moderate Alzheimer’s disease

被引：0
|
作者：
Brian R. Ott
Lesley M. Blake
Ethel Kagan
Malca Resnick
机构：
[1] Rhode Island Hospital – APC 6,The Alzheimer’s Disease & Memory Disorders Center
[2] Northwestern University,Department of Psychiatry
[3] Harborside Financial Center,Forest Laboratories, Inc.
来源：
Journal of Neurology | 2007年 / 254卷
关键词：
Alzheimer’s disease; memantine; open label; randomized controlled trial; ADAS-cog;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：351 / 358
页数：7
相关论文
共 50 条
  • [31] Safety, tolerability, and efficacy estimate of evoked gamma oscillation in mild to moderate Alzheimer's disease
    Hajos, Mihaly
    Boasso, Alyssa
    Hempel, Evan
    Shpokayte, Monika
    Konisky, Alex
    Seshagiri, Chandran V.
    Fomenko, Vitella
    Kwan, Kim
    Nicodemus-Johnson, Jessie
    Hendrix, Suzanne
    Vaughan, Brent
    Kern, Ralph
    Megerian, Jonathan T.
    Malchano, Zach
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [32] Safety and tolerability of GRF6019 in mild-to-moderate Alzheimer's disease dementia
    Hannestad, Jonas
    Koborsi, Katie
    Klutzaritz, Vicki
    Chao, Whitney
    Ray, Rebecca
    Paez, Antonio
    Jackson, Sam
    Lohr, Scott
    Cummings, Jeffrey L.
    Kay, Gary
    Nikolich, Karoly
    Braithwaite, Steven
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2020, 6 (01)
  • [33] Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study
    Salloway, Stephen P.
    Sperling, Reisa
    Fox, Nick C.
    Sabbagh, Marwan N.
    Honig, Lawrence S.
    Porsteinsson, Anton P.
    Rofael, Hany
    Ketter, Nzeera
    Wang, Daniel
    Liu, Enchi
    Carr, Stephen
    Black, Ronald S.
    Brashear, H. Robert
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 64 (03) : 689 - 707
  • [34] Donepezil Combined with Natural Hirudin Improves the Clinical Symptoms of Patients with Mild-to-Moderate Alzheimer's Disease: A 20-Week Open-Label Pilot Study
    Li, De-qiang
    Zhou, Yu-ping
    Yang, Han
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2012, 9 (03): : 248 - 255
  • [35] An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer's disease
    Kainuma, Mosaburo
    Ouma, Shinji
    Kawakatsu, Shinobu
    Iritani, Osamu
    Yamashita, Ken-Ichiro
    Ohara, Tomoyuki
    Hirano, Shigeki
    Suda, Shiro
    Hamano, Tadanori
    Hieda, Sotaro
    Yasui, Masaaki
    Yoshiiwa, Aoi
    Shiota, Seiji
    Hironishi, Masaya
    Wada-Isoe, Kenji
    Sasabayashi, Daiki
    Yamasaki, Sho
    Murata, Masayuki
    Funakoshi, Kouta
    Hayashi, Kouji
    Shirafuji, Norimichi
    Sasaki, Hirohito
    Kajimoto, Yoshinori
    Mori, Yukiko
    Suzuki, Michio
    Ito, Hidefumi
    Ono, Kenjiro
    Tsuboi, Yoshio
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [36] Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients
    Ferris, Steven
    Ihl, Ralf
    Robert, Philippe
    Winblad, Bengt
    Gatz, Gudrun
    Tennigkeit, Frank
    Gauthier, Serge
    ALZHEIMERS & DEMENTIA, 2009, 5 (05) : 369 - 374
  • [37] A 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's Disease
    Nakamura, Yu
    Strohmaier, Christine
    Tamura, Kaoru
    Kataoka, Naoko
    Nakano, Masayuki
    Oda, Shoichiro
    Nishimura, Kazuma
    Homma, Akira
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2015, 5 (03): : 361 - 374
  • [38] Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease
    Jia, Jianping
    Wei, Cuibai
    Chen, Wei
    Jia, Longfei
    Zhou, Aihong
    Wang, Fen
    Tang, Yi
    Xu, Luoyi
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (01) : 199 - 211
  • [39] Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease
    Jones, Roy W.
    Bayer, Antony
    Inglis, Fraser
    Barker, Andrew
    Phul, Ravinder
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 22 (03) : 258 - 262
  • [40] Observational study on safety, tolerability and effectiveness of galantamine in patients with mild to moderately severe Alzheimer's disease
    Blesa, R.
    Ribas, G. Garcia
    Galdos, L.
    Olascoaga, J.
    Amer, G.
    Lopez, J. Marey
    Barquero, M.
    Marsall, C.
    Ezpeleta, D.
    NEUROLOGIA, 2006, 21 (06): : 289 - 296
12345